285 related articles for article (PubMed ID: 32556142)
1. Correcting β-thalassemia by combined therapies that restrict iron and modulate erythropoietin activity.
Casu C; Pettinato M; Liu A; Aghajan M; Lo Presti V; Lidonnici MR; Munoz KA; O'Hara E; Olivari V; Di Modica SM; Booten S; Guo S; Neil G; Miari R; Shapir N; Zafir-Lavie I; Domev H; Ferrari G; Sitara D; Nai A; Rivella S
Blood; 2020 Oct; 136(17):1968-1979. PubMed ID: 32556142
[TBL] [Abstract][Full Text] [Related]
2. Global loss of Tfr2 with concomitant induced iron deficiency greatly ameliorates the phenotype of a murine thalassemia intermedia model.
Schmidt PJ; Fitzgerald K; Butler JS; Fleming MD
Am J Hematol; 2021 Feb; 96(2):251-257. PubMed ID: 33180328
[TBL] [Abstract][Full Text] [Related]
3. Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice.
Guo S; Casu C; Gardenghi S; Booten S; Aghajan M; Peralta R; Watt A; Freier S; Monia BP; Rivella S
J Clin Invest; 2013 Apr; 123(4):1531-41. PubMed ID: 23524968
[TBL] [Abstract][Full Text] [Related]
4. An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.
Schmidt PJ; Toudjarska I; Sendamarai AK; Racie T; Milstein S; Bettencourt BR; Hettinger J; Bumcrot D; Fleming MD
Blood; 2013 Feb; 121(7):1200-8. PubMed ID: 23223430
[TBL] [Abstract][Full Text] [Related]
5. Transferrin receptor 2 is a potential novel therapeutic target for β-thalassemia: evidence from a murine model.
Artuso I; Lidonnici MR; Altamura S; Mandelli G; Pettinato M; Muckenthaler MU; Silvestri L; Ferrari G; Camaschella C; Nai A
Blood; 2018 Nov; 132(21):2286-2297. PubMed ID: 30209118
[TBL] [Abstract][Full Text] [Related]
6. Deletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia.
Nai A; Pagani A; Mandelli G; Lidonnici MR; Silvestri L; Ferrari G; Camaschella C
Blood; 2012 May; 119(21):5021-9. PubMed ID: 22490684
[TBL] [Abstract][Full Text] [Related]
7. RNAi-mediated reduction of hepatic Tmprss6 diminishes anemia and secondary iron overload in a splenectomized mouse model of β-thalassemia intermedia.
Schmidt PJ; Liu K; Visner G; Fitzgerald K; Fishman S; Racie T; Hettinger JL; Butler JS; Fleming MD
Am J Hematol; 2018 Jun; 93(6):745-750. PubMed ID: 29498084
[TBL] [Abstract][Full Text] [Related]
8. Severe microcytic anemia but increased erythropoiesis in mice lacking Hfe or Tfr2 and Tmprss6.
Lee P; Hsu MH; Welser-Alves J; Peng H
Blood Cells Mol Dis; 2012 Mar; 48(3):173-8. PubMed ID: 22244935
[TBL] [Abstract][Full Text] [Related]
9. Combination of a TGF-β ligand trap (RAP-GRL) and TMPRSS6-ASO is superior for correcting β-thalassemia.
Guerra A; Hamilton N; Rivera A; Demsko P; Guo S; Rivella S
Am J Hematol; 2024 Jul; 99(7):1300-1312. PubMed ID: 38659383
[TBL] [Abstract][Full Text] [Related]
10. The erythroid function of transferrin receptor 2 revealed by Tmprss6 inactivation in different models of transferrin receptor 2 knockout mice.
Nai A; Pellegrino RM; Rausa M; Pagani A; Boero M; Silvestri L; Saglio G; Roetto A; Camaschella C
Haematologica; 2014 Jun; 99(6):1016-21. PubMed ID: 24658816
[TBL] [Abstract][Full Text] [Related]
11. Combination of Tmprss6- ASO and the iron chelator deferiprone improves erythropoiesis and reduces iron overload in a mouse model of beta-thalassemia intermedia.
Casu C; Aghajan M; Oikonomidou PR; Guo S; Monia BP; Rivella S
Haematologica; 2016 Jan; 101(1):e8-e11. PubMed ID: 26405152
[No Abstract] [Full Text] [Related]
12. SLN124, a GalNac-siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron-overload in a mouse model of β-thalassaemia.
Vadolas J; Ng GZ; Kysenius K; Crouch PJ; Dames S; Eisermann M; Nualkaew T; Vilcassim S; Schaeper U; Grigoriadis G
Br J Haematol; 2021 Jul; 194(1):200-210. PubMed ID: 33942901
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow Tfr2 deletion improves the therapeutic efficacy of the activin-receptor ligand trap RAP-536 in β-thalassemic mice.
Tanzi E; Di Modica SM; Bordini J; Olivari V; Pagani A; Furiosi V; Silvestri L; Campanella A; Nai A
Am J Hematol; 2024 Jul; 99(7):1313-1325. PubMed ID: 38629683
[TBL] [Abstract][Full Text] [Related]
14. A human anti-matriptase-2 antibody limits iron overload, α-globin aggregates, and splenomegaly in β-thalassemic mice.
Wake M; Palin A; Belot A; Berger M; Lorgouilloux M; Bichon M; Papworth J; Bayliss L; Grimshaw B; Rynkiewicz N; Paterson J; Poindron A; Spearing E; Carter E; Hudson R; Campbell M; Petzer V; Besson-Fournier C; Latour C; Largounez A; Gourbeyre O; Fay A; Coppin H; Roth MP; Theurl I; Germaschewski V; Meynard D
Blood Adv; 2024 Apr; 8(8):1898-1907. PubMed ID: 38241484
[TBL] [Abstract][Full Text] [Related]
15. Transferrin receptor 2 (Tfr2) genetic deletion makes transfusion-independent a murine model of transfusion-dependent β-thalassemia.
Di Modica SM; Tanzi E; Olivari V; Lidonnici MR; Pettinato M; Pagani A; Tiboni F; Furiosi V; Silvestri L; Ferrari G; Rivella S; Nai A
Am J Hematol; 2022 Oct; 97(10):1324-1336. PubMed ID: 36071579
[TBL] [Abstract][Full Text] [Related]
16. A critical role for murine transferrin receptor 2 in erythropoiesis during iron restriction.
Wallace DF; Secondes ES; Rishi G; Ostini L; McDonald CJ; Lane SW; Vu T; Hooper JD; Velasco G; Ramsay AJ; Lopez-Otin C; Subramaniam VN
Br J Haematol; 2015 Mar; 168(6):891-901. PubMed ID: 25403101
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with a Tmprss6 RNAi-therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of β-thalassemia intermedia.
Schmidt PJ; Racie T; Westerman M; Fitzgerald K; Butler JS; Fleming MD
Am J Hematol; 2015 Apr; 90(4):310-3. PubMed ID: 25557851
[TBL] [Abstract][Full Text] [Related]
18. A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease.
Olivari V; Di Modica SM; Lidonnici MR; Aghajan M; Cordero-Sanchez C; Tanzi E; Pettinato M; Pagani A; Tiboni F; Silvestri L; Guo S; Ferrari G; Nai A
Kidney Int; 2023 Jul; 104(1):61-73. PubMed ID: 36990212
[TBL] [Abstract][Full Text] [Related]
19. Effect of erythropoietin administration on proteins participating in iron homeostasis in Tmprss6-mutated mask mice.
Frýdlová J; Rychtarčíková Z; Gurieva I; Vokurka M; Truksa J; Krijt J
PLoS One; 2017; 12(10):e0186844. PubMed ID: 29073189
[TBL] [Abstract][Full Text] [Related]
20. Iron and hepcidin: a story of recycling and balance.
Camaschella C
Hematology Am Soc Hematol Educ Program; 2013; 2013():1-8. PubMed ID: 24319154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
